FDA Orders Device Companies to Study Risks of Surgical Mesh Implants

The Food and Drug Administration has ordered medical device companies to study and determine possible risks from their implantable surgical mesh products, according to a New York Times report.

Advertisement

Read the full report in Becker’s Hospital Review on implantable surgical mesh.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.